Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited financial results of the Company for the quarter and half year ended 30.09.2025.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has submitted to NSE the copy of the newspaper publication of its unaudited financial results for the quarter and half year ended 30th September 2025. Under SEBI listing rules, listed companies are required to publish their quarterly/half-yearly results in at least one English and one regional language newspaper within 48 hours of submitting them to the stock exchanges. This filing is a compliance formality confirming that the publication requirement has been fulfilled.
No direct impact on shareholders or stock price — this is a routine regulatory disclosure. Investors should look at the actual financial results (already filed separately) for revenue, profit, and margin trends to gauge the company's performance.